PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Summary

RATIONALE: PV701 may be able to kill tumor cells while leaving normal cells undamaged. PURPOSE: Phase I trial to study the effectiveness of PV701 in treating patients who have advanced or recurrent ovarian epithelial, fallopian tube, primary peritoneal, colorectal, or other cancer found primarily within the peritoneal cavity.

Timeline

Start

2003-01

Primary completion

—

Completion

—

Drugs

Indications